Influence of Kidney Function Estimation Methods on Eligibility for Edoxaban Population Impact of the US Food and Drug Administration's Approach for Its Product Labeling.

Journal Article (Clinical Trial;Letter)

Full Text

Duke Authors

Cited Authors

  • Pokorney, SD; Shrader, P; Thomas, L; Fonarow, GC; Kowey, PR; Singer, DE; Ansell, J; Gersh, BJ; Mahaffey, KW; Hylek, EM; Go, AS; Piccini, JP; Peterson, ED; Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators,

Published Date

  • October 11, 2016

Published In

Volume / Issue

  • 134 / 15

Start / End Page

  • 1122 - 1124

PubMed ID

  • 27753615

Electronic International Standard Serial Number (EISSN)

  • 1524-4539

Digital Object Identifier (DOI)

  • 10.1161/CIRCULATIONAHA.116.024333

Language

  • eng

Conference Location

  • United States